EW(Edwards Lifesciences Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $5.23B | $4.46B | $5.01B | $5.44B | $6.07B |
| 毛利润 | $3.98B | $3.74B | $4.03B | $4.32B | $4.73B |
| 营业利润 | $1.69B | $1.50B | $1.31B | $1.38B | $1.26B |
| 净利润 | $1.50B | $1.52B | $1.40B | $4.17B | $1.07B |
| 经营现金流 | $1.73B | $1.22B | $895.80M | $542.30M | $1.60B |
| 自由现金流 | $1.41B | $973.60M | $642.80M | $289.90M | $1.33B |
| 摊薄每股收益 | $2.38 | $2.44 | $2.30 | $6.97 | $1.83 |